ReviewClinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
Study on Cerebral Venous Thrombosis From 2014 to 2023: A Bibliometric Analysis via CiteSpace.
Review in Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
ObjectiveWe aimed to explore the development status, turning and key points, and emerging trends of the cerebral venous thrombosis (CVT).MethodsLiterature pertaining to CVT published from 2014 to 2023 in the Web of Science Core Collection database was searched. The 6.3.R1 version of CiteSpace software was used to conduct a bibliometric analysis.ResultsA total of 2421 articles were ultimately retained. The annual publication volume exhibited a general trend of gradual growth, culminating in 2022. In terms of both publication volume and citation frequency, the journal "Stroke" emerges as the preeminent publication with high quantity and quality. The United States, China and India have become the foremost contributors while Pakistan and England exhibit a strong international collaboration. Ferro JM from Universidade de Lisboa, Coutinho JM from University of Amsterdam and Ji XM from Capital Medical University from are identified as the leading scholars. Burst analyses of keyword and co-cited references reveal that prior to 2021, the predominant research topics in the field of CVT were epidemiology, diagnosis and management, with increased attention to endovascular therapies and novel imaging modalities. From 2021 to 2023, the focus has shifted primarily to COVID-19 and vaccine-induced immune thrombotic thrombocytopenia (VITT).ConclusionOver the past decade, research on CVT has demonstrated continuous growth. The most influential institutions and scholars were from Europe and China. Our analysis showed that core research priorities in CVT centered on epidemiology, diagnosis and management while the COVID-19 pandemic temporarily shifted focus toward COVID-19 and VITT associated CVT.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.